Decrease in vitamin D receptor and calcium-sensing receptor in highly proliferative parathyroid adenomas

European Journal of Endocrinology

Volumn 148, Issue 4, 2003, Pages 403-411

  Yano, Shozo ^a,c   Sugimoto, Toshitsugu ^a   Tsukamoto, Tatsuo ^a   Chihara, Kazuo ^a   Kobayashi, Akira ^b   Kitazawa, Sohei ^a   Maeda, Sakan ^a   Kitazawa, Riko ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Kobayashi Clinic   (Japan)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CALCIUM SENSING RECEPTOR; KI 67 ANTIGEN; MONOCLONAL ANTIBODY; PARATHYROID HORMONE; VITAMIN D RECEPTOR;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; DISEASE SEVERITY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LABELING INDEX; ORGAN SIZE; ORGAN WEIGHT; PARATHYROID ADENOMA; PARATHYROID GLAND; PARATHYROIDECTOMY; PRIMARY HYPERPARATHYROIDISM; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REGRESSION ANALYSIS; SCORING SYSTEM; STATISTICAL ANALYSIS; THYROID CARCINOMA; TISSUE SECTION; TUMOR DIFFERENTIATION; WESTERN BLOTTING;

ADENOMA; ADULT; AGED; AGED, 80 AND OVER; CELL DIVISION; HUMANS; HYPERPARATHYROIDISM; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MIDDLE AGED; PARATHYROID GLANDS; PARATHYROID NEOPLASMS; RECEPTORS, CALCITRIOL; RECEPTORS, CALCIUM-SENSING; RECEPTORS, CELL SURFACE; REGRESSION ANALYSIS;

EID: 0038069520     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1480403     Document Type: Article

References (48)

1. (2+)-sensing receptor from bovine parathyroid. Nature 1993 366 575-580.
2. (2+)-sensing receptor gene cause familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Cell 1993 75 1297-1303.
3. Pearce SH, Williamson C, Kifor O, Bai M, Coulthard MG, Davies M et al. A familial syndrome of hypocalcemia with hypercalciuria due to mutations in the calcium-sensing receptor. New England Journal of Medicine 1996 335 1115-1122.
4. Ho C, Conner DA, Pollak MR, Ladd DJ, Kifor O, Warren HB et al. A mouse model of human familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Nature Genetics 1995 11 389-394.
5. (2+)-sensing receptor in primary and uremic secondary hyperparathyroidism. Journal of Clinical Endocrinology and Metabolism 1996 81 1598-1606.
6. Gogusev J, Duchambon P, Hory B, Giovannini M, Goureau Y, Sarfati E et al. Depressed expression of calcium receptor in parathyroid gland tissue of patients with hyperparathyroidism. Kidney International 1997 51 328-336.
7. Yano S, Sugimoto T, Tsukamoto T, Chihara K, Kobayashi A, Kitazawa S et al. Association of decreased calcium-sensing receptor expression with proliferation of parathyroid cells in secondary hyperparathyroidism. Kidney International 2000 58 1980-1986.
8. Brown AJ, Ritter CS, Finch JL & Slatopolsky EA. Decreased calcium-sensing receptor expression in hyperplastic parathyroid glands of uremic rats: role of dietary phosphate. Kidney International 1999 55 1284-1292.
9. Silver J, Russell J & Sherwood LM. Regulation by vitamin D metabolites of messenger RNA for pre-proparathyroid hormone in isolated bovine parathyroid cells. PNAS 1985 82 4270-4273.
10. 3. Journal of Biological Chemistry 1988 263 2203-2208.
11. Hughes MR, Malloy PJ, Kieback DG, Kesterson RA, Pike JW, Feldman D et al. Point mutations in the human vitamin D receptor gene associated with hypocalcemic rickets. Science 1988 242 1702-1705.
12. Yoshizawa T, Handa Y, Uematsu Y, Takeda S, Sekine K, Yoshihara Y et al. Mice lacking the vitamin D receptor exhibit impaired bone formation, uterine hypoplasia and growth retardation after weaning. Nature Genetics 1997 16 391-396.
13. Kremer R, Bolivar I, Goltzman D & Hendy GN. Influence of calcium and 1,25-dihydroxycholecalciferol on proliferation and proto-oncogene expression in primary cultures of bovine parathyroid cells. Endocrinology 1989 125 935-941.
14. 3 inhibits parathyroid cell proliferation in experimental uremia. Kidney International 1989 35 1049-1056.
15. 3 in the parathyroid glands of patients with renal failure. New England Journal of Medicine 1987 316 1573-1577.
16. 3 receptor density is associated with a more severe form of parathyroid hyperplasia in chronic uremic patients. Journal of Clinical Investigation 1993 92 1436-1443.
17. Gerdes J, Li L, Schlueter C, Duchrow M, Wohlenberg C, Gerlach C et al. Immunobiochemical and molecular biologic characterization of the cell proliferation-associated nuclear antigen that is defined by monoclonal antibody Ki-67. American Journal of Pathology 1991 138 867-873.
18. Wang Q, Palnitkar S & Parfitt AM. Parathyroid cell proliferation in the rat. Effect of age, and of phosphate administration and recovery. Endocrinology 1996 137 4558-4562.
19. Parfitt AM, Wang Q & Palnitkar S. Rates of cell proliferation in adenomatous, suppressed and normal parathyroid tissue: implications for pathogenesis. Journal of Clinical Endocrinology and Metabolism 1998 83 863-869.
20. Kamel OW, LeBrun DP, Davis RE, Berry GJ & Warnke RA. Growth fraction estimation of malignant lymphomas in formalin-fixed paraffin-embedded tissue using anti-PCNA/cyclin 19A2. Correlation with Ki-67 labeling. American Journal of Pathology 1991 138 1471-1477.
21. Frolich M, Walma ST, Paulson C & Papapoulos SE. Immunoradiometric assay for intact human parathyroid hormone: characteristics, clinical application and comparison with a radioimmunoassay. Annals of Clinical Biochemistry 1990 27 69-72.
22. (2+) receptor: characterization and use in studying concanavalin A inhibition. Journal of Bone and Mineral Research 1997 12 1780-1788.
23. Gundersen HJG, Bendtsen TF, Korbo L, Marcussen N, Moller A, Nielsen K et al. Some new, simple and efficient stereological methods and their use in pathological research and diagnosis. Acta Pathologica, Microbiologica et Immunologica Scandinavica 1988 96 379-394.
24. Bai M, Trivedi S & Brown EM. Dimerization of the extracellular calcium-sensing receptor (CaR) on the cell surface of CaR-transfected HEK293 cells. Journal of Biological Chemistry 1998 273 23605-23610.
25. Lloyd HM, Jacobi JM, Willgoss D, Kearney J & Ward P. DNA synthesis and secretory activity in parathyroid adenomas. Acta Endocrinologica 1981 96 70-74.
26. Loda M, Lipman J, Cukor B, Bur M, Kwan P & DeLellis RA. Nodular foci in parathyroid adenomas and hyperplasias: an immunohistochemical analysis of proliferative activity. Human Pathology 1994 25 1050-1056.
27. Tominaga Y, Tsuzuki T, Uchida K, Haba T, Otsuka S, Ichimori T et al. Expression of PRAD1/cyclin D1, retinoblastoma gene products, and Ki67 in parathyroid hyperplasia caused by chronic renal failure versus primary adenoma. Kidney International 1999 55 1375-1383.
28. Farnebo F, Hoog A, Sandelin K, Larsson C & Farnebo LO. Decreased expression of calcium-sensing receptor messenger ribonucleic acid in parathyroid adenomas. Surgery 1998 124 1084-1098.
29. (2+)-sensing receptor gene in human parathyroid tumors. Journal of Clinical Endocrinology and Metabolism 1995 80 3107-3110.
30. Cetani F, Pinchera A, Pardi E, Cianferotti L, Vignali E, Picone A et al. No evidence for mutations in the calcium-sensing receptor gene in sporadic parathyroid adenomas. Journal of Bone and Mineral Research 1999 6 878-882.
31. Canaff L & Hendy GN. Human calcium-sensing receptor gene: vitamin D response elements in promoters P1 and P2 confer transcriptional responsiveness to 1,25-dihydroxyvitamin D. Journal of Biological Chemistry 2002 277 30337-30350.
32. Brown AJ, Zhong M, Finch J, Ritter C, McCracken R, Morrissey J et al. Rat calcium-sensing receptor is regulated by vitamin D but not by calcium. American Journal of Physiology 1996 270 F454-F460.
33. Carling T, Rastad J, Szabo E, Westin G & Akerstrom G. Reduced parathyroid vitamin D receptor messenger ribonucleic acid levels in primary and secondary hyperparathyroidism. Journal of Clinical Endocrinology and Metabolism 2000 85 2000-2003.
34. Rao DS, Han ZH, Phillips ER, Palnltkar S & Parfitt AM. Reduced vitamin D receptor expression in parathyroid adenomas: implications for pathogenesis. Clinical Endocrinology 2000 53 373-381.
35. Trydal T, Varhaug JE, Myking A, Aksnes L, Aakvaag A & Aarskog D. Serum vitamin D metabolites and calcitriol receptor concentration in parathyroid tissue in primary hyperparathyroidism. Acta Endocrinologica 1992 127 407-412.
36. Koike T, Fukuda N, Fukagawa M, Ohta K & Kurokawa K. Correlation of enhanced cell proliferation with decreased density of vitamin D receptor in parathyroid hyperplasia in chronic dialysis patients. Nephrology 1997 3 279-284.
37. 3 receptor in rats. Biochemical and Biophysical Research Communications 1986 137 742-747.
38. 3 in the regulation of vitamin D receptor expression by rat parathyroid glands. Endocrinology 1995 136 1419-1425.
39. Sriussadaporn S, Wong MS, Pike JW & Favus MJ. Tissue specificity and mechanism of vitamin D receptor up-regulation during dietary phosphorus restriction in the rat. Journal of Bone and Mineral Research 1995 10 271-280.
40. 3 receptor in vivo. PNAS 1989 86 9770-9773.
41. 3 receptor gene expression by parathyroid hormone and cAMP-agonists. Biochemical and Biophysical Research Communications 1992 185 881-886.
42. 3 in cultured bovine parathyroid cells. Endocrinology 1992 130 276-281.
43. 3 in the parathyroid in vivo. Journal of Clinical Investigation 1990 86 1968-1975.
44. Hsu CH, Patel RS & Vanholder R. Mechanism of decreased intestinal calcitriol receptor concentration in renal failure. American Journal of Physiology 1993 264 F662-F669.
45. Reinhardt TA & Horst RL. Parathyroid hormone down-regulates 1,25-dihydroxyvitamin D receptors (VDR) and VDR messenger ribonucleic acid in vitro and blocks homologous up-regulation of VDR in vivo. Endocrinology 1990 127 942-948.
46. Wu H & Arnold A. Vitamin D receptor gene as a candidate tumor suppressor gene in parathyroid adenomas. Journal of Bone and Mineral Research 1996 11 S488 (Abstract).
47. Wada M, Furuya Y, Sakiyama J, Kobayashi N, Miyata S, Ishii H et al. The calcimimetic compound NPS R-568 suppresses parathyroid cell proliferation in rats with renal insufficiency: control of parathyroid cell growth via a calcium receptor. Journal of Clinical Investigation 1997 100 2977-2983.
48. Silverberg SJ, Bone HG III, Marriott TB, Locker FG, Thys-Jacobs S, Dziem G et al. Short-term inhibition of parathyroid hormone secretion by a calcium-receptor agonist in patients with primary hyperparathyroidism. New England Journal of Medicine 1997 337 1506-1510.